Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by ANALIAS00on Nov 14, 2020 10:35am
115 Views
Post# 31901082

RE:RE:RE:More insider buying: Littlejohn, Gary Peter almost 8k shares

RE:RE:RE:More insider buying: Littlejohn, Gary Peter almost 8k sharesThis is not a bad news for sure. I will not complain but my comment or my question is what does represent this investment for this person ? 500$ for me ? If he realy was expecting a positive impact on the SP mid term, even just a little 25%, he would have bougth a lot more. This sound like a standard and minimum investment required when joining a new board. A polite gesture. Are they finally be annoncing that filling was completed ? Mid november already....again they keep missing their own agenda.
Thao977 wrote: Yesterday, Molson bought 24k. 3625976 2020-10-16 2020-11-13 Proprit directe : 00 - Solde d'ouverture-Dclaration initiale en format SEDI 3625977 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +19,200 2.9300 19,200 3625978 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +400 2.8800 19,600 3625979 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +2,100 2.9200 21,700 3625980 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +2,000 2.9000 23,700 3625981 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +300 2.9500 24,000


Bullboard Posts